DOLUTEGRAVIR 50 mg + LAMIVUDINE 300 mg (Twinaqt) x 30 Tablets

Benefits of DOLUTEGRAVIR 50 mg + LAMIVUDINE 300 mg

• Helps control and manage HIV infection
• Supports lowering the viral load in the body
• May help strengthen immune system function
• Combines two antiretroviral medicines in one treatment
• Supports long-term HIV treatment management
• Used under medical supervision

Side Effects

• Headache
• Nausea or vomiting
• Diarrhea
• Tiredness or fatigue
• Difficulty sleeping (insomnia)
• Dizziness
• Loss of appetite
• Increased liver enzymes (may show in blood tests)
• Muscle or joint pain

Caution

• Take exactly as prescribed.
• Do not skip or stop doses.
• Inform your doctor of kidney or liver problems.
• Monitor kidney function regularly.
• Avoid alcohol while on treatment.
• Do not share medication.

Dolutegravir 50 mg and Lamivudine 300 mg Price and Reimbursement Information by Country

Dolutegravir 50 mg and Lamivudine 300 mg prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.

• View Dolutegravir with lamivudine medicinal-form and pricing information on NICE BNF (UK) – https://bnf.nice.org.uk/drugs/lamivudine-with-dolutegravir/medicinal-forms/
• View Dovato (dolutegravir/lamivudine) pricing information on Drugs.com (USA) – https://www.drugs.com/price-guide/dovato
• View Dolutegravir with lamivudine PBS assessment information (Australia) – https://www.pbs.gov.au/industry/pbac/psd/2019/08/dolutegravir-with-lamivudine-psd-7-2019-addenda-08-2019-and-09-2019.pdf?variant=3
• View Dolutegravir 50 mg with lamivudine 300 mg subsidy information on the National Drug Formulary (Singapore) – https://www.ndf.gov.sg/about-drugs/active-ingredient/m01628/